SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001365916-20-000092
Filing Date
2020-06-04
Accepted
2020-06-04 17:12:26
Documents
8
Period of Report
2020-06-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8k0604020.htm 8-K 86761
2 EX-3.1 exhibit318k060420.htm EX-3.1 106595
3 EX-10.1 exhibit1018k060420.htm EX-10.1 289121
4 EX-10.2 exhibit1028k060420.htm EX-10.2 72198
5 EX-99.1 exhibit9918k060420.htm EX-99.1 13728
6 image01.jpg GRAPHIC 8544
7 image011.jpg GRAPHIC 114
8 image11.jpg GRAPHIC 114
  Complete submission text file 0001365916-20-000092.txt   582247
Mailing Address 5885 HOLLIS STREET, SUITE 100 EMERYVILLE CA 94608
Business Address 5885 HOLLIS STREET, SUITE 100 EMERYVILLE CA 94608 510-450-0761
AMYRIS, INC. (Filer) CIK: 0001365916 (see all company filings)

IRS No.: 550856151 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34885 | Film No.: 20943681
SIC: 2860 Industrial Organic Chemicals